Skip to contentLieber Jonathan I — Altus Pharmaceuticals Inc. insider: 66 transactions · InsiderLensLieber Jonathan I
- Chief Financial Officer at Rallybio Corp · on record since Mar 16, 2023
- SVP, CFO and Treasurer at Altus Pharmaceuticals Inc. · on record since May 27, 2008
- CFO at REPLIGEN CORP · on record since Sep 24, 2012
- Chief Financial Officer at Ocugen, Inc. · on record since Jun 22, 2015
- Director at FIRST HORIZON PHARMACEUTICAL CORP · on record since Jun 22, 2020
- See Remarks at Checkmate Pharmaceuticals, Inc. · on record since Aug 6, 2020
- Chief Financial Officer at APPLIED GENETIC TECHNOLOGIES CORP · on record since Sep 21, 2021
Insider trading activity of Lieber Jonathan I
- Transactions on record
- 66
- since Nov 17, 2006
- Open-market buys
- 3
- $42.9K
- Open-market sells
- 11
- $351.8K
- Companies traded
- 6
- last filing Feb 23, 2026
Figures computed from official regulatory filings — methodology.
Companies where Lieber Jonathan I has traded
Track record of Lieber Jonathan I
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Lieber Jonathan I
Co-insiders of Lieber Jonathan I
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
ADAR1 Capital Management, LLCRallybio Corp
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 23, 2026 | Sell | -789 | 5.06 USD | $4K | SEC |
| Feb 23, 2026 | Award | 2,500 | 0.00 USD | $0 | SEC |
| Feb 19, 2025 | AwardD | 180,000 | 0.00 USD | $0 | SEC |
| Feb 22, 2024 | AwardD | 20,500 | 0.00 USD | $0 | SEC |
| Feb 16, 2024 | AwardD | 120,000 | 0.00 USD | $0 | SEC |
| Mar 16, 2023 | Buy | 5,000 | 5.21 USD | $26.1K | SEC |
| Feb 1, 2023 | AwardD | 240,000 | 0.00 USD | $0 | SEC |
| Jan 5, 2023 | Award | 1,440 | 0.00 USD | $0 | SEC |
| Dec 1, 2022 | OtherD | -154,700 | — | — | SEC |
| Dec 1, 2022 | OtherD | -202,000 | — | — | SEC |
| Aug 24, 2022 | AwardD | 154,700 | 0.00 USD | $0 | SEC |
| Jun 8, 2022 | Buy | 37,500 | 0.19 USD | $7.1K | SEC |
| Jan 21, 2022 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Sep 21, 2021 | AwardD | 202,000 | 0.00 USD | $0 | SEC |
| Dec 4, 2020 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jul 16, 2020 | AwardD | 3,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | OtherD | -28,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | AwardD | 130,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | AwardD | 110,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | OtherD | -130,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | OtherD | -50,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | AwardD | 28,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | OtherD | -110,000 | 0.00 USD | $0 | SEC |
| Oct 3, 2018 | OtherD | -30,000 | 0.00 USD | $0 | SEC |